Benlysta and Lovenox drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Benlysta (belimumab) and Lovenox (enoxaparin sodium). Common drug interactions include anuria among females and memory impairment among males.

The phase IV clinical study analyzes what interactions people have when they take Benlysta and Lovenox. It is created by eHealthMe based on reports of 24 people who take the same drugs from the FDA, and is updated regularly.

What is Benlysta?

Benlysta has active ingredients of belimumab. It is often used in systemic lupus erythematosus. eHealthMe is studying from 23,528 Benlysta users. Check the latest studies of Benlysta.

What is Lovenox?

Lovenox has active ingredients of enoxaparin sodium. It is often used in deep venous thrombosis. eHealthMe is studying from 48,149 Lovenox users. Check the latest studies of Lovenox.



On Aug, 06, 2026

24 people who take Benlysta and Lovenox together, and have interactions are studied.

Benlysta and Lovenox drug interactions.

What are the common drug interactions of Benlysta and Lovenox, by gender? *:

female:

  1. Anuria (failure of the kidneys to produce urine)
  2. Influenza a virus test positive
  3. Lung infection
  4. Progressive multifocal leukoencephalopathy (rapidly progressive neuromuscular disease caused by opportunistic infection of brain cells)
  5. Respiratory distress (difficulty in breathing)
  6. Fatigue (feeling of tiredness)
  7. Nausea (feeling of having an urge to vomit)
  8. Abdominal pain
  9. Abdominal pain upper
  10. Anaemia (lack of blood)

male:

  1. Memory impairment
  2. Actinic keratosis (skin disease due to sun exposure)
  3. Rhinorrhoea (watery mucus discharge from the nose)
  4. White blood cell count decreased
  5. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  6. Confusional state
  7. Feeling cold
  8. Haematocrit decreased
  9. Headache (pain in head)
  10. Monoplegia (a paralysis of a single limb)

What are the common drug interactions of Benlysta and Lovenox, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Anuria (failure of the kidneys to produce urine)
  2. Influenza a virus test positive
  3. Lung infection
  4. Respiratory distress (difficulty in breathing)
  5. Abdominal pain
  6. Hypochromic anaemia (hypochromic anaemia is a generic term for any type of anaemia in which the red blood cells (erythrocytes) are paler than normal)
  7. Influenza
  8. Intestinal ischaemia (decreased supply of oxygenated blood to the intestines)
  9. Mitral valve incompetence (inefficient heart valve)
  10. Multi-organ failure (multisystem organ failure)

30-39:

  1. Abdominal pain upper
  2. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  3. Cholangitis (infection of the bile duct)
  4. Disturbance in attention
  5. Drug ineffective
  6. Neutropenia (an abnormally low number of neutrophils)
  7. Pneumonia

40-49:

  1. Anaemia (lack of blood)
  2. Drug administration error
  3. Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters)
  4. Haemorrhage (bleeding)

50-59:

  1. Fatigue (feeling of tiredness)
  2. Nausea (feeling of having an urge to vomit)
  3. Cystitis (inflammation of the wall of the bladder)
  4. Femur fracture
  5. Local swelling (swelling at the site of some application of substance or injury)
  6. Nerve injury
  7. Pelvic haematoma (collection of blood outside of a blood vessel in pelvic region)

60+:

  1. Progressive multifocal leukoencephalopathy (rapidly progressive neuromuscular disease caused by opportunistic infection of brain cells)
  2. Memory impairment
  3. Pain in extremity
  4. Rhinorrhoea (watery mucus discharge from the nose)
  5. White blood cell count decreased
  6. Actinic keratosis (skin disease due to sun exposure)
  7. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  8. Confusional state
  9. Feeling cold
  10. Haematocrit decreased

What are the existing conditions these people have? *

  1. High Blood Pressure: 2 people, 8.33%
  2. Depression: 2 people, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Benlysta and Lovenox?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Benlysta and Lovenox:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Benlysta:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Lovenox:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Benlysta and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Lovenox and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on belimumab and enoxaparin sodium (the active ingredients of Benlysta and Lovenox, respectively), and Benlysta and Lovenox (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: